|
Volumn 4, Issue 3, 2007, Pages 128-129
|
Avoid the tragedy of hepatitis B reactivation in immunosuppressed patients: Commentary
|
Author keywords
[No Author keywords available]
|
Indexed keywords
INFLIXIMAB;
LAMIVUDINE;
CHEMOPROPHYLAXIS;
CLINICAL TRIAL;
DRUG EFFICACY;
DRUG USE;
FOLLOW UP;
HEPATITIS B;
HUMAN;
IMMUNE DEFICIENCY;
INCIDENCE;
LIVER FUNCTION TEST;
MEDLINE;
META ANALYSIS;
MORTALITY;
OUTCOME ASSESSMENT;
PATIENT MONITORING;
PRIORITY JOURNAL;
SHORT SURVEY;
SYSTEMATIC REVIEW;
VIRUS CARRIER;
VIRUS MUTATION;
VIRUS REACTIVATION;
|
EID: 33947199899
PISSN: 17434378
EISSN: 17434386
Source Type: Journal
DOI: 10.1038/ncpgasthep0740 Document Type: Short Survey |
Times cited : (5)
|
References (4)
|